Syros Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Syros Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $-0.59 | $-0.77 | 23.4 % |
Mar 2024 | 2024-05-14 | $-0.10 | $-0.87 | 88.5 % |
Dec 2023 | 2024-03-27 | $-2.18 | $-1.14 | -91.2 % |
Sep 2023 | 2023-11-14 | $-1.43 | $-1.14 | -25.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $0 | $460.00K | -100.0 % |
Mar 2024 | 2024-05-14 | $0 | $720.00K | -100.0 % |
Dec 2023 | 2024-03-27 | $387.00K | $2.00M | -80.7 % |
Sep 2023 | 2023-11-14 | $3.76M | $3.94M | -4.52 % |
Syros Pharmaceuticals (SYRS) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
The Actual EPS was $-0.59, which beat the estimate of $-0.77.
The Actual Revenue was $0K, which missed the estimate of $460K.
Browse earnings estimates, EPS, and revenue on all stocks.